Our findings suggest the function of PGRMC1 as an important amplifier of ERα-dependent transcription upon treatment with the PPPs NET, DYD, DSP, and MPA, resulting in oncogenic signaling and tumor progression in ERα positive breast cancer cells. Here, PGRMC1 is linked to breast cancer.